The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can. Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Prof. Hossam Haick of the Technion – Israel Institute of Technology, one of Israel’s most successful scientists, is really a frustrated karate fighter. As a boy in Nazareth, he joined a karate class and seemed to have found his calling. “I was incredibly competitive,” he says. “I went from one achievement to the next.” But […]
The Nobel Assembly at Karolinska Institutet announced Monday that professors Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Medicine, with two of the three laureates having received the Technion-Israel Institute of Technology Harvey Prize. Prof. Deisseroth of the Howard Hughes Medical Institute and Stanford University, USA, and Prof. Hegemann […]
A breast cancer diagnosis can bring a terrifying question: Will chemotherapy save my life, or will I endure its painful side effects without any benefit? In this video, influencer Aija Mayrock goes inside the Technion – Israel Institute of Technology with Dr. Gil Shamai to explore an AI breakthrough that could help doctors answer that […]
A Breakthrough From the Technion Together with collaborators from leading medical centers in Israel, the United States, Europe, and Australia, Shamai and his team at the Technion have developed an AI model that predicts both the risk that breast cancer will return and whether a patient is likely to benefit from chemotherapy — offering a […]
An Israeli medical researcher has helped shed new light on a mystery that has endured for nearly 340 years: what killed Queen Christina of Sweden, one of 17th-century Europe’s most unusual monarchs. Prof. Zaid Abassi of the Technion – Israel Institute of Technology’s, Ruth and Bruce Rappaport Faculty of Medicine and Rambam Health Care Campus, […]
Artificial intelligence is rapidly becoming an integral part of our lives, and a working tool for professionals in a variety of fields, including medicine, which integrates AI in order to reach faster, more accurate, and more efficient diagnoses. But to what extent can AI truly be relied upon when it comes to complex medical decisions? […]
Few medical decisions seem so simple, yet create so much uncertainty: Is the infection bacterial, and therefore potentially in need of antibiotics, or viral, meaning antibiotics will not help? For years, physicians have tried to answer that question using symptoms, blood tests and tests that directly search for the virus or bacteria. Israeli company MeMed […]
Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the other, the treatment does nothing. Oncologists still have no reliable way to tell these patients apart before therapy begins. Why does immunotherapy succeed for some and fail for others? A new study led […]